Every Thursday we send out a curated newsletter on “all things femtech and women’s health innovation”. This is the latest edition. If you’re interested in subscribing, you can do so at the bottom of this page.
Tia launches virtual care at their second location in Los Angeles; Feinstein Institutes has been awarded $4M to research perinatal depression; Mae launches a maternal health platform for expectant black mothers; Pregna launches Cryopop, a carbon dioxide based cryotherapy device to fight cervical cancer; Nuvo seeks FDA approval for remote monitoring of maternal uterine activity; SynSexRx, a new drug tackles the relationship between obesity and breast cancer; Kountable and Proof Market partner to solve Digital ID and deliver rapid diagnostic testing for women across the global South; SimpleHealth waives consultation fee for unemployed women needing access to birth control; The Medical Student Forum on Female Sexual Medicine took place last weekend
You’ve found some of our exclusive Inner Circle Content.
This article is only available for our Inner Circle Members. To read on:
Kathrin Folkendt is the Founder & CEO of Femtech Insider, the globally leading publication on all things femtech. She usually writes about women's health innovation, health equity, and entrepreneurship.